Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Children affected by rifampicin-resistant tuberculosis (RR-TB; TB resistant to at least rifampicin) are a neglected group. Each year an estimated 25,000–30,000 children develop RR-TB disease globally. Improving case detection and treatment initiation is a priority since RR-TB disease is underdiagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Howell, Pauline, Achar, Jay, Huang, G. Khai Lin, Mariandyshev, Andrei, Schaaf, H. Simon, Garcia-Prats, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024964/
https://www.ncbi.nlm.nih.gov/pubmed/35456056
http://dx.doi.org/10.3390/pathogens11040381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024964/
https://www.ncbi.nlm.nih.gov/pubmed/35456056
http://dx.doi.org/10.3390/pathogens11040381

Ejemplares similares